President Trump Signs Executive Order to Accelerate Psychedelic Research, Including Ibogaine
President Trump has signed an executive order to ease research restrictions on psychedelics, such as ibogaine, a substance used in some regions for treating post-traumatic stress disorder. The order aims to speed up access to new medical research and treatments, with a $50 million federal investment planned. It also opens a pathway for ibogaine...